Definium Therapeutics Inc (DFTX)
EBITDA Growth
-290.42%
Quarterly · Period ending:
DFTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-290.42%period ending
Latest reported-290.42%period ending
DFTX Quarterly EBITDA YoY % (49.18% → -290.42%)
Year-over-year change
High-resolution chart · PNG
DFTX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -290.4197% | |
| -230.7043% | |
| -22.1223% | |
| -5,780.9492% | |
| -649.9258% | |
| 57.4356% | |
| -44.5783% | |
| 93.323% | |
| 80.9362% | |
| -123.146% | |
| -461.0017% | |
| -7.0659% | |
| -75.1441% | |
| -35.7289% | |
| 76.6612% | |
| 3.965% | |
| 63.6587% | |
| -32.7815% | |
| -17.4045% | |
| -118.4017% | |
| -654.144% | |
| -224.1766% | |
| -363.7405% | |
| -3,453.4312% | |
| -2,377.0215% | |
| -635.2541% | |
| 64.3296% | |
| 30.9258% | |
| 23.0574% | |
| 56.7818% | |
| -13.0428% | |
| 13.8414% | |
| 49.1755% |